Why PetMed Express Shares Fell
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of PetMed Express were looking under the weather today, falling as much as 11% after a disappointing second-quarter earnings report.
So what: The pet pharmacy came up short on the bottom line, delivering a per-share profit of $0.21 on expectations of $0.22. Revenue was up 4% to $60.5 million, edging past estimates of $60.3 million, but investors seemed to be focused on the bottom line. CEO Menderes Akdag noted that reorders increased 5.3% and that the average order size grew from $72 to $73, while profits were also helped by a decrease in advertising expense.
Now what: Considering PetMed's track record of beating earnings estimates in the last four quarters, shareholders seemed taken aback by the surprise miss. Still, the sell-off seems unwarranted for only missing earnings estimates by a penny. What seemed to put a dent into profits was the rising cost of medicine, as gross profit actually fell from a year ago. Management made no comment about that development in its release, but investors may want to see more than one quarter of results to determine whether that's a trend.
Invest like a boss
The best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.
The article Why PetMed Express Shares Fell originally appeared on Fool.com.Fool contributor Jeremy Bowman and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.